MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino acid peptide encoded by the mitochondrial genome. It is often referred to as a “mitokine” or “exercise mimetic” because it helps regulate metabolic homeostasis and mimics many of the cellular signals produced during physical exertion.

As of 2026, here is a summary of the reported benefits, mechanisms, and current data landscape.

Core Metabolic & Health Benefits

Research—predominantly in preclinical (animal) models—highlights several primary therapeutic areas:

1. Metabolic Flexibility & Weight Management
   • AMPK Activation: MOTS-c acts on the AMPK pathway, the body’s “master metabolic switch.” This increases glucose uptake in skeletal muscle and promotes fatty acid oxidation (fat burning).
   • Obesity Prevention: In mice fed high-fat diets, MOTS-c administration has been shown to prevent weight gain and reduce visceral fat accumulation.
   • Insulin Sensitivity: It can reverse age-dependent insulin resistance, acting similarly to the diabetes drug metformin by improving how cells handle sugar.
2. Physical Performance & Muscle Health
   • Exercise Mimicry: It enhances physical performance and endurance. Studies on mice at various life stages (young to old) showed improved motor coordination and treadmill running capacity after treatment.
   • Sarcopenia Prevention: Data suggests it may combat age-related muscle loss by inhibiting myostatin (a protein that limits muscle growth) and promoting muscle fiber homeostasis.
3. Longevity & Cellular Health
   • Mitochondrial Biogenesis: MOTS-c stimulates the creation of new, healthy mitochondria, which typically decline in number and function as we age.
   • Stress Resistance: Under metabolic stress, the peptide translocates to the cell nucleus to regulate gene expression, helping cells survive oxidative stress and inflammation.
   • Osteoporosis: Emerging 2023–2025 data indicates MOTS-c promotes osteoblast (bone-forming cell) differentiation, suggesting a role in maintaining bone density.